The Net Margin of Fusen Pharmaceutical Co Ltd (1652.HK) is -4.31%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -4.31% |
| 2024-12-31 | -57.90% |
| 2023-12-31 | -6.41% |
| 2022-12-31 | -7.04% |
| 2021-12-31 | 4.32% |
| 2020-12-31 | 14.40% |
| 2019-12-31 | 13.12% |
| 2018-12-31 | 22.05% |
| 2017-12-31 | 21.39% |
| 2016-12-31 | 21.51% |